Orthopedic Devices - CIS

  • CIS
  • The Orthopedic Devices market market in the Commonwealth of Independent States (in Commonwealth of Independent States (CIS)) is anticipated to achieve a revenue of US$0.52bn by the year 2024.
  • Looking ahead, the market is expected to display a steady annual growth rate (CAGR 2024-2029) of 3.91%, leading to a market volume of US$0.63bn by 2029.
  • In terms of global comparison, the United States is projected to generate the highest revenue, amounting to US$16,020.00m in 2024.
  • In the CIS region, the demand for orthopedic devices is growing steadily due to an aging population and an increase in sports-related injuries.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in CIS is witnessing significant growth due to various factors such as increasing prevalence of orthopedic disorders, rising geriatric population, and advancements in medical technology.

Customer preferences:
Customers in the CIS region have a strong preference for orthopedic devices that are technologically advanced, durable, and cost-effective. They prioritize devices that offer improved functionality, comfort, and long-term sustainability. Additionally, customers also prefer devices that are easy to use and require minimal maintenance.

Trends in the market:
One of the key trends in the Orthopedic Devices market in CIS is the growing demand for joint replacement surgeries. As the population ages, the incidence of orthopedic disorders such as osteoarthritis is increasing. This has led to a rise in the number of joint replacement surgeries, driving the demand for orthopedic devices such as hip and knee implants. Another trend in the market is the increasing adoption of minimally invasive procedures. Minimally invasive surgeries offer several benefits such as shorter hospital stays, reduced post-operative pain, and faster recovery. This has led to a shift towards minimally invasive orthopedic procedures, driving the demand for specialized orthopedic devices and instruments.

Local special circumstances:
The CIS region comprises several countries with varying healthcare systems and economic conditions. While some countries have well-developed healthcare infrastructure and high healthcare expenditure, others have limited resources and infrastructure. This creates a diverse market landscape for orthopedic devices in the region. In addition, the CIS region is characterized by a large rural population, which poses unique challenges in terms of accessibility to healthcare facilities and orthopedic devices. Manufacturers need to consider these local special circumstances and adapt their product offerings to cater to the specific needs of the population in different regions.

Underlying macroeconomic factors:
The Orthopedic Devices market in CIS is influenced by various macroeconomic factors. Economic growth, government healthcare policies, and reimbursement systems play a crucial role in shaping the market dynamics. Countries with robust economic growth and favorable healthcare policies are likely to witness higher demand for orthopedic devices. Furthermore, the increasing disposable income and changing lifestyles in the CIS region have led to a rise in healthcare expenditure. This has resulted in increased affordability and accessibility to orthopedic devices, driving market growth. In conclusion, the Orthopedic Devices market in CIS is experiencing significant growth due to factors such as increasing prevalence of orthopedic disorders, rising geriatric population, and advancements in medical technology. Customer preferences for technologically advanced and cost-effective devices, along with the trends of joint replacement surgeries and minimally invasive procedures, are shaping the market. Local special circumstances, such as diverse healthcare systems and the rural population, need to be considered by manufacturers. Additionally, underlying macroeconomic factors such as economic growth and government healthcare policies are also influencing the market dynamics.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)